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Aside from human papillomavirus (HPV), the role of other risk factors in cervical cancer
such as age, education, parity, sexual partners, smoking and human immunodeficiency
virus (HIV) have been described but never ranked in order of priority. We evaluated the con-
tribution of several known lifestyle co-risk factors for cervical cancer among black South Afri-
can women.
Methods
We used participant data from the Johannesburg Cancer Study, a case-control study of
women recruited mainly at Charlotte Maxeke Johannesburg Academic Hospital between
1995 and 2016. A total of 3,450 women in the study had invasive cervical cancers, 95% of
which were squamous cell carcinoma. Controls were 5,709 women with cancers unrelated
to exposures of interest. Unconditional logistic regression models were used to calculate
adjusted odds ratios (ORadj) and 95% confidence intervals (CI). We ranked these risk fac-
tors by their population attributable fractions (PAF), which take the local prevalence of expo-
sure among the cases and risk into account.
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Results
Cervical cancer in decreasing order of priority was associated with (1) being HIV positive
(ORadj = 2.83, 95% CI = 2.53–3.14, PAF = 17.6%), (2) lower educational attainment (ORadj =
1.60, 95% CI = 1.44–1.77, PAF = 16.2%), (3) higher parity (3+ children vs 2–1 children
(ORadj = 1.25, 95% CI = 1.07–1.46, PAF = 12.6%), (4) hormonal contraceptive use (ORadj =
1.48, 95% CI = 1.24–1.77, PAF = 8.9%), (5) heavy alcohol consumption (ORadj = 1.44, 95%
CI = 1.15–1.81, PAF = 5.6%), (6) current smoking (ORadj = 1.64, 95% CI = 1.41–1.91, PAF =
5.1%), and (7) rural residence (ORadj = 1.60, 95% CI = 1.44–1.77, PAF = 4.4%).
Conclunsion
This rank order of risks could be used to target educational messaging and appropriate inter-
ventions for cervical cancer prevention in South African women.
Introduction
Cervical cancer is the fourth most frequently occurring cancer type and the fourth leading
cause of death from cancer among women globally [1]. In sub-Saharan Africa (SSA), more
than 101,423 new cases and 76,444 deaths of cervical cancer occur each year [1]. In South
Africa, the age-standardised incidence rate of cervical cancer as reported by Globocan is 44.4
per 100,000 women per year [1]. According to the 2017 South African National Cancer Regis-
try report, there were 5,630 new histologically confirmed cases of cervical cancer amongst
black women with a lifetime risk (0–74 years) of 1 in 33 women [2].
The main risk factor for cervical cancer and its premalignant lesions is persistent infection
with high-risk Human papillomaviruses (hr-HPV) [3]. A previous study from the Johannes-
burg Cancer Study (JCS), showed a seroprevalence of 78% for anti HPV-16 antibodies in cervi-
cal cancer cases [4]. However, at least 90% of women with hr-HPV infection, do not develop
cervical cancer [3]. This suggests that other environmental cofactors acting jointly with hr-
HPV elevate the risk of cervical carcinogenesis [5].
Epidemiological studies have indicated human immunodeficiency virus (HIV), parity,
smoking, alcohol consumption, contraceptive use, age, education and number of sexual part-
ners to be cofactors of cervical cancer pathogenesis [5–12], but these cofactors vary in preva-
lence (and possibly the risk) in different settings. Understanding the prevalence levels of
different cofactors and their risk for cervical cancer in a local setting may help in identifying
risk profiles to target in cervical cancer prevention.
In South Africa, studies on some lifestyle-related cofactors for cervical cancer were pub-
lished about 10 years ago from the JCS [13–15]. These studies focused separately on individual
cofactors such as HIV [15], smoking [14] or contraceptive use [13]. Among black South Afri-
can women little is known about the relative importance of these cofactors for cervical cancer.
In South Africa, the JCS was established in 1995 to redress at that time the historical paucity
of epidemiological cancer research among black South Africans [16]. The JCS aimed to exam-
ine whether key known and emerging risk factors for cancer in women of mainly European
ancestry applied to patients of African ancestry in Johannesburg, South Africa. These aims
evolved into measuring the importance of known and emerging risk factors for cancer in a
local setting.
We analysed JCS lifestyle data to evaluate the contribution of different cofactors in the path-
ogenesis of cervical cancer among black South African women. In the current study, we used a
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subset of the JCS female samples and focused on ages 25 to 64 years to align with current cervi-
cal screening guidelines but also allowing for a more comparable assessment of the contribu-
tion of different cofactors in rank order to the risk of cervical cancer.
Methods
Setting and participants
The details of the JCS have been described elsewhere [16], but briefly, the JCS recruited over
26,000 black South African patients (both sexes) who were newly diagnosed with an incident
cancer between 1995 and 2016. Recruitment took place mainly at Charlotte Maxeke-Johannes-
burg Academic Hospital medical oncology and radiotherapy clinics and associated peripheral
clinics. Trained interviewers collected self-reported data on demographics and key lifestyle
risk factors from consenting participants using a structured questionnaire, and took peripheral
blood samples for HIV and other analyses. The questionnaire included questions on the fol-
lowing: socio-demographic factors such as; place of birth and residence, marital status, educa-
tion, the home language of parents. Enviromental exposures such as method of cooking and
heating. Lifestyle factors such as; smoking by type of tobacco and amounts smoked, snuff
(sniffed tobacco) use, alcohol consumption by type, parity, use of oral and injectable contra-
ceptives, number of sexual partners. On occupations, self-reported use of Anti-Retroviral
Therapy (ART) (since 2005), PAP smear (2001) and self-reported history of diabetes. The JCS
and the current study were approved by the University of the Witwatersrand Human Research
Ethics Committee (Medical) (certificate number for the current study. M200252). In the JCS,
participants gave written informed or wittnessd consent to once-off interview and optional
blood draw and to have their information and blood sample anonymized. Any future investi-
gations require approval of the University of the Witwatersrand Human Research Ethics Com-
mittee HREC [16].
Selection of cases and controls
The JCS is amenable to a case-control design and analysis. Cases were women who were newly
diagnosed with invasive cervical cancer (histologically confirmed squamous cell carcinoma
and adenocarcinoma) and controls were designated as women with newly diagnosed cancers
that have no known relationship with the exposures of interest [16].
A total of, 26,263 participants were enrolled in the JCS between 1995 to 2016. We excluded
8,677 (33.0%) males, 3,105 (17.6%) women older than 65 years or younger than 25 years, 663
(4.6%) non-cancer participants, 945(6.9%) non-South Africans, 1 with missing data, 640
(5.0%) with missing HIV-status and 691 (5.7%) with primary site unknown malignancy. From
those with cancer of the cervix, we excluded International Classification of Diseases for Oncol-
ogy (ICD-O) codes such as (ICD-O morphology: 8010–8050 epithelial neoplasm (n = 98,
2.6%), (ICD-O morphology: 8000 and 8001) not otherwise specified (n = 9, 0.2%), (ICD-O
morphology: 8560, 8570 and 8574) complex epithelial neoplasms (n = 108, 2.8%) and other
minor histological types (ICD-O morphology: 8098,8170, 8200, 8272, 8310, 8441,8460, 8480–
8490, 8500,8650 and 8931–9100) (n = 64, 1.7%) Fig 1.
Fig 1 also outlines the criteria used to select cases and controls. The control groups were
arranged into four sets. Each set comprised of women diagnosed with different cancer types
that are unrelated to the exposures of interest (these being infection, smoking, alcohol, parity,
number of sexual partners and use of hormonal contraceptives) [16–18] Fig 1. Cancer controls
unrelated to infection constituted the highest number of controls S1 Table. The demographic
analyses excluded 2,009 (26.0%) women with cancers related to infections. Analyses relating to
smoking excluded 2,218 (28.7%) women with cancers related to smoking and infections.
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Analyses relating to alcohol excluded 6,800 (60.4%) women with cancers related to alcohol and
infections. Analyses relating to hormonal contraceptives excluded 6,458 (57.4%) women with
cancers related to hormonal contraceptives and infections. Of the remaining 9,249 women,
3,540 (38.3%) had invasive cervical cancer (defined as cases) and 5,709 (61.7%) had other can-
cers (defined as controls) that were not related to the exposure of interest Fig 1.
Definition of exposures
For other demographic factors, women were grouped according to the period of the interview
(1995–1999, 2000–2004, 2005–2009, 2010–2016), education level (none, primary, secondary
and tertiary and unknown), marital status (never married, married, ever married and
unknown) and place of residence (rural, urban and unknown).
Women’s HIV status (positive and negative) was based on Abbott Axysm HIV1/2 gO
Microparticle Enzyme-linked Immunoassay (ELISA) (1995 to 2005) and the Vironostika (HIV
UniForm II plus O) micro ELISA (2006 to 2016) test results [15], while the other cofactors
Fig 1. Data flow diagram on the selection exposure unrelated cancer controls.
https://doi.org/10.1371/journal.pone.0260319.g001
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were self-reported. Use of hormonal contraceptive was categorized into (never (injectable and
oral), ever oral/ not injectable, ever injectable/ not oral, ever oral, injectable and ever injectable
and/ or oral) and unknown [13]. Parity was categorized into 1–2,> = 3 children and unknown.
We excluded 168 (1.9%) women who had never given birth (on assumption that some may
have had pre-existing unreported gynaecological conditions or hysterectomies). The number of
sexual partners for the participants were grouped into 0–1, 2–5,> = 6 and unknown.
Women’s smoking status was classified into never (non-smokers), ex-smoker, current
smoker and unknown. The current smokers included those women who reported to have quit
smoking within 5 years of interview (diagnosis) to reduce the likelihood of reverse causation
[14]. We calculated total alcohol consumption based on different types of alcoholic beverages
consumed: spirits (homebrew and commercial), beer (homebrew and commercial), wine,
maize and sorghum, the content of ethanol from each type of alcohol beverages and the num-
ber of drinks per day. The average number of drinks per week was used to calculate the total
alcohol consumption [19]. We defined one drink as to have drunk 15.7 grams of unmixed
alcohol beverage, which is equivalent to one bottle of beer of 340ml that contains 4% of etha-
nol. Based on the Center for Disease Control (CDC) definitions [20], we categorized women’s
self-reported consumption of alcoholic beverages into never, light (31.4 grams or less of alco-
hol per week) and heavy (47.1 grams or more of alcohol per week).
Statistical analysis
Demographic characteristics were summarized using frequencies and percentages for the cate-
gorical variables, medians and the interquartile range (IQR) for the continuous variable that
was not normally distributed. We then analyzed the relationship between each of the six cofac-
tors with cervical cancer, using the appropriate set of cancer controls for each analysis Fig 1.
We assessed for HIV status in model 1, parity in model 2, smoking in model 3, alcohol con-
sumption in model 4; hormonal contraceptive use in model 5, and the number of sexual part-
ners in model 6. We fitted our data using a backward stepwise multivariable unconditional
logistic regression to estimate the unadjusted and adjusted odds ratios (ORadj) and 95% confi-
dence intervals (CI). In the final multivariable analysis of each model, we returned to the
model variables where literature supported an association with cervical cancer. We ran 6 dif-
ferent models with different main exposures. We adjusted simultaneously for the potential
confounders: age (grouped), the period of the interview, marital status, place of residence and
education level. We performed a test for heterogeneity on categorical variables and a score test
for trends in the odds ratios on ordinal categorical variables using unconditional logistic
regression Table 2. We used a Pearson correlation matrix to test for multicollinearity between
independent variables in each model [21]. We used the Mantel-Haesnzel Chi-square test to
assess differences in the prevalence of cofactors across different cancer types in different sets of
controls Table 3.
Population attributable fractions





[22]; where Pei is the proportion of cases exposed to a particular cofactor
and i is the exposure level. When a variable had three categories, we added the PAF for the cat-
egories. A PAF % represents the proportion of the disease attributable to a particular exposure.
We then ranked the cofactors which were significant based on their PAF. All the statistical
tests were done using STATA software version 16.0 (Stata Corp, college station, Tx). Statistical
significance was considered at a two-sided α-level of 0.05.
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Results
Controls were relatively older compared to cases (Median age 50 years (IQR: 42–57) versus 48
years (IQR: 41–55)). The highest percentage of participants were in the age group of 45–54
years: 36.4% among cervical cancer cases and 33.8% among controls. Most of the study partici-
pants (cases = 84.2% and controls = 90.4%) lived in urban areas. More than half of the partici-
pants (58.5%) achieved a secondary or greater level of education Table 1.
Cases had nearly three times the risk of being HIV positive compared to controls (ORadj
2.83, 95% CI: 2.54–3.15). After controlling for the common set of confounders, a strong trend
of elevated risk with higher parity was observed, relative to 1–2 children, with odds ratios of
Table 1. Demographics: Cervical cancer cases and infection unrelated cancer control participants from the JCS.
Characteristics Total (N = 9249 Cases (N = 3540 Controls (N = 5709
(100%)) (100%)) (100%))






Median (IQR) 49 (42–56) 48 (41–55) 50 (42–57)
Age
25–34 795 (8.6) 286 (8.1) 525 (8.9)
35–44 2410 (26.1) 1010 (28.5) 1400 (24.5)
45–54 3220 (34.8) 1288 (36.4) 1932 (33.8)
55–64 2824(30.5) 956 (27.1) 1868 (32.7)
Period of interview
1995–1999 1619 (17.5) 766 (21.6) 853 (14.8)
2000–2004 1455 (15.7) 477 (13.5) 978 (17.1)
2005–2009 2544 (27.5) 994 (28.1) 1550 (27.2)
2010–2016 3631 (39.3) 1303 (36.8) 2328 (40.8)
Marital Status
Never Married 2224 (24.1) 861 (24.3) 1363 (23.9)
Married 4152 (44.8) 1581 (44.7) 2571 (45.0)
Ever married 2848 (30.8) 1088 (30.7) 1760 (30.8)
Missing data 25 (0.3) 10 (0.3) 15 (0.3)
Place of Residence
Rural 1069 (11.5) 546 (15.4) 524 (9.1)
Urban 8181 (88.1) 2982 (84.2) 5190 (90.4)
Missing data 39 (0.4) 13 (0.4) 26 (0.5)
Education Level
None 1037 (11.2) 515 (14.6) 522 (9.1)
Primary 2772 (30.0) 1202 (34.0) 1570 (27.5)
Secondary 4930 (53.3) 1707 (48.2) 3223 (56.5)
Tertiary 479 (5.2) 97 (2.7) 379 (6.6)
Missing data 34 (0.4) 19 (0.5) 15 (0.3)
Cancer Controls are unrelated to infection, Ever married includes widowed and divorced, IQR = Interquartile range, SCC = Squamous Cell Carcinoma,
JCS = Johannesburg Cancer Study
https://doi.org/10.1371/journal.pone.0260319.t001
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Table 2. Multivariable analysis of lifestyle risk factors and cervical cancer participants from the JCS.
Characteristics Total (N = 9249)
N (%)
Cases (N = 3540)
n (%)
Controls
(N = 5709) n (%)
Unadjusted OR
(95%CI)







25–34 795 (8.6) 286 (8.1) 525 (8.9) 1.10 (0.93–1.29) 1.00 (0.96–1.37) 0.906
35–44 2410 (26.1) 1010 (28.5) 1400 (24.5) 1.41 (1.26–1.58) 1.34 (1.17–1.52) <0.001
45–54 3220 (34.8) 1288 (36.4) 1932 (33.8) 1.30 (1.17–1.45) 1.28 (1.14–1.43) <0.001
55–64 2824(30.5) 956 (27.1) 1868 (32.7) 1.00 1.00
p-value (trend) <0.001 0.016
Period of interview
1995–1999 1619 (17.5) 766 (21.6) 853 (14.8) 1.00 1.00
2000–2004 1455 (15.7) 477 (13.5) 978 (17.1) 0.54 (0.47–0.63) 0.53 (0.45–0.62) <0.001
2005–2009 2544 (27.5) 994 (28.1) 1550 (27.2) 0.71 (0.63–0.81) 0.67 (0.59–0.77) <0.001
2010–2016 3631 (39.3) 1303 (36.8) 2328 (40.8) 0.62 (0.55–0.70) 0.59 (0.51–0.68) <0.001
p-value (trend) <0.001 <0.001
Marital Status
Never Married 2224 (24.1) 861 (24.3) 1363 (23.9) 1.00 1.00
Married 4152 (44.8) 1581 (44.7) 2571 (45.0) 0.99 (0.87–1.12) 1.14 (1.01–1.28) 0.023
Ever married 2848 (30.8) 1088 (30.7) 1760 (30.8) 1.00 (0.87–1.14) 1.11 (0.98–1.27) 0.061





Rural 1069 (11.5) 546 (15.4) 524 (9.1) 1.85 (1.62–2.01) 1.62 (1.41–1.86) <0.001
Urban 8181 (88.1) 2982 (84.2) 5190 (90.4) 1.00 1.00





None 1037 (11.2) 515 (14.6) 522 (9.1) 1.97 (1.72–2.25) 2.01 (1.73–2.34) <0.001
Primary 2772 (30.0) 1202 (34.0) 1570 (27.5) 1.53 (1.39–1.68) 1.60 (1.44–1.77) <0.001
Secondary and
above
5406 (58.5) 1804 (51.0) 3223 (63.1) 1.00 1.00





HIV Status Model 1
Negative 6759 (72.8) 2217 (62.6) 4542 (79.0) 1.00 1.00
Positive 2550 (27.2) 1323 (37.4) 1207 (21.0) 2.32 (2.10–2.54) 2.83 (2.53–3.14) <0.001





1–2 1595 (33.2) 1138 (32.2) 457 (35.5) 1.00 1.00
3+ 3021 (668.9) 2288 (65.0) 733 (57.0) 1.49 (1.36–1.63) 1.25 (1.07–1.46) 0.005
Missing data 190 (4.0) 94 (2.7) 96 (7.5) 0.65 (0.50–0.83) 0.57 (0.44–0.74) 0.002
p-value (trend) <0.001 0.002
Smoking Model 3
(Continued)
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1.25 (95% CI: 1.07–1.46) for women reporting three or more children Table 2. Compared to
never smokers, the risk of cervical cancer significantly increased among women who were cur-
rent smokers (ORadj 1.55, 95% CI: 1.34–1.80) and ex-smokers (ORadj 1.26, 95% CI: 1.02–1.55).
The odds ratios for cervical cancer were 1.44 (95% CI: 1.26–1.65) for women in the age group
35–44 years and 1.33 (95% CI: 1.18–1.50) for those in the age group 45–54 years old compared
to women in the age group 55–64 years. The risk of cervical cancer increased among married
women compared to never married (ORadj 1.14, 95% CI: 1.01–1.28). The risk of cervical cancer
Table 2. (Continued)
Characteristics Total (N = 9249)
N (%)
Cases (N = 3540)
n (%)
Controls
(N = 5709) n (%)
Unadjusted OR
(95%CI)





Never 6737(83.3) 2830 (79.9) 3807 (85.9) 1.00 1.00
Ex-Smoker 424 (5.3) 209 (5.9) 215 (4.8) 1.31 (1.07–1.59) 1.26 (1.02–1.55) 0.030
Current 901 (11.3) 498 (14.1) 403 (9.2) 1.66 (1.44–1.91) 1.55 (1.34–1.80) <0.001




Alcohol consumption Model 4
Never 3538 (79.3) 2781 (78.6) 757 (82.5) 1.00 1.00
Light 243 (5.5) 194 (5.5) 49 (5.3) 1.08 (0.77–1.49) 1.20 (0.86–1.68) 0.287
Heavy 677 (15.2) 565 (16.0) 112 (12.2) 1.37 (1.10–1.71) 1.44 (1.15–1.81) 0.002




Contraceptive use Model 5
Never (injectable
and oral)
1833 (38.2) 1262 (35.7) 571 (45.3) 1.00 1.00
Ever Oral/ not
injectable
578 (12.0) 408 (11.5) 170 (13.5) 1.09 (0.89–1.33) 1.09 (0.88–1.36) 0.847
Ever Injectable/ not
oral
1526 (31.8) 1226 (34.5) 305 (24.2) 1.81 (1.54–2.13) 1.34 (1.11–1.61) 0.002
Ever oral and
Injectable
844 (17.6) 637 (18.0) 207 (16.4) 1.39 (1.16–1.68) 1.22 (1.00–1.50) 0.366
Ever injectable and/
or oral
2948 (61.4) 2266 (64.0) 709 (54.5) 1.50 (1.32–1.71) 1.17 (1.01–1.37) 0.039







0–1 661 (7.2) 233 (6.6) 428 (7.5) 1.00 1.00
2–5 5384 (58.0) 2123 (60.0) 3243 (56.8) 1.20 (1.01–1.42) 1.15 (0.96–1.37) 0.129
6+ 1007 (10.9) 397 (11.2) 610 (10.7) 1.20 (0.98–1.47) 1.11 (0.89–1.38) 0.298
Missing data 2215 (24.0) 787 (22.2) 1428 (25.0) 1.01 (0.84–1.21) 1.09 (0.88–1.34) 0.378
p-value (trend) 0.040 0.020
Notes
a. The total for alcohol, smoking and contraceptive do not add up to the whole total because some of the cancers were removed from the list of controls (see Table 3 in
the appedix).
b. Odds Ratios were adjusted for age, education level, marital status, period of the interview, place of residence (rural and urban).
c. The sets of controls that were used are different in each model depending on the association between the exposure and cervical cancer.
https://doi.org/10.1371/journal.pone.0260319.t002
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among women who reported having consumed at least 47.1 grams of alcohol per week (heavy
alcohol consumption) was 44% higher (ORadj 1.44, 95% CI: 1.15–1.81) compared to women
who reported having never consumed alcohol. Cases were more likely than controls to have
ever used injectable contraceptives (ORadj 1.34, 95% CI: 1.11–1.61) and ever used oral or
injectable contraceptives (ORadj 1.17, 95% CI: 1.01–1.37). A lower level of educational attain-
ment was associated with an increased risk of cervical cancer: Education (None versus Second-
ary and above ORadj 2.01, 95% CI: 1.73–2.34) and (Primary versus Secondary and above ORad
1.60, 95% CI: 1.44–1.77). Living in rural compared to urban areas increased the risk of cervical
cancer by 62% (ORadj 1.62,95% CI: 1.44–1.77).
Our estimated PAF of cervical cancer for the 7 modifiable cofactors ranged from HIV(positive)
(17.6%), lower education attainment (no education or primary) (16.9%), higher parity (3+ children)
(12.6%), contraceptive use (Ever injectable and/ or oral) (8.9%), alcohol consumption (light and
heavy) (5.6%), smoking (ex-smoker and current smoker) (5.1%) and 4.4% for the place of residence
(rural) Fig 2. The number of sexual partners were excluded as it was not statistically significant.
We tested the robustness of our control selections on the assumption that the prevalence of
exposure for each of the cancer types chosen in each of the comparisons should be homoge-
neous. We therefore, calculated an adjusted (age, number of sexual partners and education
level) Mantel-Haenszel Chi-square tests of heterogeneity for each type of comparisons. We
observed no differences (p> 0.05) in the prevalence of cofactors across different cancer types
in the three control arms except for alcohol Table 3.
Discussion
In descending order, cervical cancer was associated with being HIV-positive, educational
attainment, higher parity, contraceptive use, heavy consumption of alcohol, current smoking
and residing in rural areas among black South African women.
In the current study, cervical cancer risk was significantly associated with HIV infection,
which was ranked as the most important risk factor, with a PAF of 17.6%. This implies that
about 18% of cervical cancers would be prevented if individuals were not infected with HIV.
This is particularly important in South Africa where black women are disproportionally
affected by HIV compared to other racial groups [23]. The association between HIV and cervi-
cal cancer is supported by several studies in low- and middle-income countries [24, 25], show-
ing that during HPV pathogenesis, coinfection with HIV increases HPV viral persistence [25].
Our finding is similar to the previous study on the spectrum of HIV-1 related cancers in South
Africa which used the JCS data. In that study, the risk of cervical cancer was elevated in HIV-1
positive women, OR = 1.6 (95% CI: 1.1–2.3) [26]. Similarly, in a Ugandan study, HIV positive









Co-factors �DF Chi- square p-value DF Chi-square #p-value DF Chi-square p-value DF Chi-square p-value
Parity - - - - - - - - - 10 9.02 0.417
HIV 9 15.2 0.076 - - - - - - - - -
Number sexual partner 9 11.02 0.274 - - - - - - - - -
Smoking - - - 3 5.44 0.142 - - - - - -
Alcohol use - - - - - - 8 17.13 0.029 - - -
Contraceptive use - - - - - - - - - 15 30.82 0.051
�DF = degrees of freedom
#p-value <0.05
https://doi.org/10.1371/journal.pone.0260319.t003
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women had an increased risk for cervical cancer (ORadj = 2.4, 95% CI: 1.1–4.4) [8]. Efforts to
reduce new HIV infections among black women in South Africa would likely reduce the inci-
dence of cervical cancer in these women in future.
High incidence rates of cervical cancer have been reported among women with low socio-
economic status in both high and low-income settings [27, 28]. Socio-economic status may
affect cervical cancer incidence via levels of educational attainment. Education, a measure of
socio-economic status, is inversely related to cervical cancer risk [29]. In a study from Spain
and Columbia having no education was associated with cervical cancer (OR = 2.5, 95% CI:
1.6–3.9) [30]. Similarly, our study found having no education or completing primary school
was associated with an increased risk of cervical cancer. Our results indicate that 16.9% of the
cervical cancers would have been prevented if women with primary education had secondary
and above education. Future investments in education should drive cervical cancer rates
downwards.
In our study, higher parity (was possibly related with age at first sexual debut and possibly
early exposure to HPV infection) was associated with the risk of developing cervical cancer
and a PAF of 12.6%. Our findings are in agreement with Briton et al. [31], Castellsague et al.
[5] and Jensen et al. [32] who demonstrated an association between higher parity (2 or more
children) and cervical cancer risk. The International Agency for Research on Cancer (IARC)
showed a 3.8 (95% CI: 2.7–5.5) times risk for cervical cancer with 7 or more full-term pregnan-
cies [33]. Having 2 or more children was associated with persistent HPV infection which facili-
tated the development of cervical cancer [32]. Similar to our study, PAF’s of between 24% and
44% were reported for the USA and Italy [34] and 42% in Costa Rica for higher parity [10].
Evidence suggests that the burden of cervical cancer should decrease if average family sizes
decrease [33, 35].
Prolonged use of hormonal contraceptive has been associated with cervical cancer [36]. A
previous study from the JCS demonstrated an association between the duration of hormonal
contraceptive use and cervical cancer [13]. In our study, we did not consider the duration of
contraceptive use and cervical cancer. Nonetheless, we reported OR = 1.48 (95% CI: 1.24–
1.77) and a PAF of 8.9%. Our findings which showed an association between the use of both
injectable and oral contraceptive use and cervical cancer are broadly similar to the JCS findings
of Urban et al. [13], (OR = 1.38, 95% CI: 1.08–1.77), as well as for injectable only and cervical
cancer (OR = 1.58, 95% CI: 1.16–2.15). Our finding is also comparable to that of Appleby et al.
[36], which contains earlier JCS data, where combined contraceptive use was associated with
cervical cancer. Similarly, in Latin America, Herrero et al. [37] found an association between
injectable contraceptive use and cervical cancer, which reduces significantly after cessation of
use. Thus, prolonged use of hormonal contraceptives should be time-limited to avoid excess
risks.
The evidence concerning alcohol consumption and the risk for cervical cancer is equivocal.
Some studies demonstrated an association with alcohol consumption [9, 38, 39] but others did
not [40, 41]. Our study, however, found a significantly elevated risk for cervical cancer in
heavy drinkers. Our data on PAF suggest that 5.6% of cervical cancer cases would be avoided if
alcohol consumption were reduced. It is possible that women who were heavy drinkers in our
study may have also been involved in other high-risk behaviours such as smoking, having mul-
tiple sexual partners and other behaviours that promote the acquisition of hr-HPV [42]. Nota-
bly, lack of enough data on cervical screening made it difficult to control for it, thus we can not
preclude the effects of residual confounding.
Current smoking has consistently been associated with cervical cancer pathogenesis. We
reported an OR of 1.55 (95% CI: 1.34–1.80) for current smokers and a PAF of 5.1% for smok-
ing. A 2008 JCS study, found current smokers in South Africa had an increased risk of cervical
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cancers relative to never smokers (OR = 1.5, 95% CI: 1.2–1.8) [43]. Similarly, Roula et al. [44]
in a European prospective cohort study, showed current smokers had a Hazard Ratio (HR) of
1.6 (95% CI: 1.4–2.5) for cervical cancer. Besides, a 2011 international study by IARC showed
that current smokers compared to never smokers had a OR = 1.94 (95% CI: 1.26–2.98) risk of
developing cervical cancer [45]. While smoking is an important risk factor for cervical in other
populations, it might not be as important a risk factor in black South African women, where
the prevalence of smoking is low (4.1%) [46]. Continuing progressive anti-smoking laws and
health promotion in South Africa is needed to retain low smoking prevalence among Black
females.
We found an association between residing in the rural area and cervical cancer. Our finding
is comparable to the findings of Yang et al. [47], which showed an association between rural
area and cervical cancer (OR = 1.46, 95% CI: 1.03–2.06) and a PAF of 4.4%. This could be due
to a lack of cervical cancer screening services, poverty in rural areas, lower education attain-
ment and low uptake in cervical cancer screening. Vhuromu et al. [48], reported low utiliza-
tion of cervical cancer screening in rural areas. Improved health systems and new methods of
cervical cancer screening services in rural areas may result in an improved uptake in cervical
cancer screening. Such efforts would likely reduce cervical cancer cases in rural areas.
Sexual intercourse is the main route for HPV transmission. Having multiple sexual partners
increases the risk of HPV infection among women which may result in cervical cancer. Other
studies have demonstrated an association between the number of sexual partners and cervical
cancer risk [49, 50]. Liu et al. [49], used a meta-analysis of 41 studies and found the number of
sexual partners was an independent risk factor for cervical cancer even after adjusting for HPV
infection. Appleby et al. [50], in an international collaboration of 21 epidemiological studies
demonstrated an association between the number of sexual partners and cervical cancer. In
our study, we did not find an association between the number of sexual partners and the risk
of cervical cancer. However, there was a small increase in risk which was not significant
Table 2. The possible explanation for non signifanct finding in our study could be a result of
small samples size among women aged 25–34, reporting bias (erroneously reporting fewer
Fig 2. Population attributable fraction of the cofactors on cervical cancer.
https://doi.org/10.1371/journal.pone.0260319.g002
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sexual partners than in reality), confounding by HIV, and no partner data available on male
partners.
Our study supports the importance given to the cofactors of cervical cancer and the need
for effective interventions of these cofactors. In South Africa, cervical cancer rates could
increase or decrease depending on the effectiveness of public health policies. The PAF takes
into account the prevalence of the cofactor and adjusted odds ratios, underscoring that an
increase in the prevalence of these cofactors could have a notable effect on cervical cancer inci-
dence among black women in South Africa.
There are some strengths to our study. The larger sample size allowed us to estimate the
contribution of key lifestyle cofactors more reliably than before. The selection of appropriate
sets of cancer controls unrelated to a specific exposure of interest minimised the bias of the
estimates related to the exposure, and referral, interviewer and recall biases [17, 18]. Both cases
and controls were patients with cancers and they are likely to remember their past exposures
in a similar way. This is the first study that attempts to measure the relative importance of a
wide range of risk factors for cervical cancer in the same study population, by adjusting for a
common set of confounders.
This study has several limitations. The effects obtained were not adjusted for frequency of
Pap smear screening since the data available was self-reported and the question of Pap smear
was only added in 2001. We could not control for unmeasured confounders despite adjusting
for known confounders such as age and HIV status. Since the study only focused on black
South African women, mainly resident in Johannesburg and Soweto, the findings from this
study may not be generalizable to the entire population of South Africa. Another limitation of
this case-control study is reverse causality whereby people with long-standing conditions may
change their lifestyle. We mitigated this by reclassifying those who reported quitting smoking
five years before diagnosis as current smokers, in case they altered their habits because of
underlying health problems. Although the questions on alcohol consumption were focused on
before the participant became ill, we could not perform a similar re-classification as for smok-
ing. Because different exposures required different control selections, we avoided measuring
combined exposures e.g. smoking and drinking.
In conclusion, in order of importance, HIV-positivity, educational attainment, parity, hor-
monal contraceptive use, alcohol, smoking and residing in rural area were associated with cer-
vical cancer among black South African women. These women should be prioritized in
opportunistic or planned cervical cancer screening programs. Our findings confirm previosuly
known cofactors of cervical cancer and provide a rank order of risks that could be used locally
to target educational messaging and appropriate interventions.
Supporting information





We acknoweldge all who provided feedback to improve the manuscript.
Author Contributions
Conceptualization: Mwiza Gideon Singini.
PLOS ONE Ranking lifestyle risk factors for cervical cancer
PLOS ONE | https://doi.org/10.1371/journal.pone.0260319 December 8, 2021 12 / 15
Data curation: Wenlong Carl Chen, Melitah Motlhale, Abram Bunya Kamiza, Mazvita
Muchengeti.
Formal analysis: Mwiza Gideon Singini.
Funding acquisition: Freddy Sitas, Debbie Bradshaw, Cathryn M. Lewis, Christopher G.
Mathew, Tim Waterboer, Robert Newton.
Investigation: Debbie Bradshaw, Christopher G. Mathew, Tim Waterboer, Robert Newton,
Elvira Singh.
Methodology: Mwiza Gideon Singini.
Software: Mwiza Gideon Singini.
Supervision: Freddy Sitas, Elvira Singh.
Visualization: Wenlong Carl Chen.
Writing – original draft: Mwiza Gideon Singini.
Writing – review & editing: Mwiza Gideon Singini, Freddy Sitas, Debbie Bradshaw, Wenlong
Carl Chen, Melitah Motlhale, Abram Bunya Kamiza, Chantal Babb de Villiers, Cathryn M.
Lewis, Christopher G. Mathew, Tim Waterboer, Robert Newton, Mazvita Muchengeti,
Elvira Singh.
References
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